Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0B53
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,402
Award facts
- Contract value 100% obligated
- $1,401.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $1,401.93 by the Defense Logistics Agency on October 27, 2025. This delivery order, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, represents a firm fixed-price award with an ultimate completion date of October 28, 2025. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place at the contractor's Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499.999 billion through December 31, 2036. The broader PPV-G GEN V program, representing a $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to supply comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's portfolio includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The contractor has demonstrated substantial performance capacity through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, with no identified subcontractor relationships in the award documentation.
Quick answers
Who was awarded contract SPE2DU26F0B53?
SPE2DU26F0B53 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DU26F0B53 worth?
The government has obligated $1,402 on SPE2DU26F0B53.
Is contract SPE2DU26F0B53 an order under another contract?
Yes. SPE2DU26F0B53 is a delivery order under SPE2DU25D9815, an indefinite delivery contract.
Was contract SPE2DU26F0B53 competed?
The extent of competition for SPE2DU26F0B53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award